LOUISE HECKER to Protein Kinase Inhibitors
This is a "connection" page, showing publications LOUISE HECKER has written about Protein Kinase Inhibitors.
Connection Strength
0.125
-
Leveraging ageing models of pulmonary fibrosis: the efficacy of nintedanib in ageing. Eur Respir J. 2021 11; 58(5).
Score: 0.125
Connection Strength
The connection strength for concepts is the sum of the scores for each matching publication.
Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.